Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Parravano, Mariacristina ^a   Menchini, Francesca ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; STEROID; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY;

ANTIANGIOGENIC THERAPY; BIOMICROSCOPY; BLOOD VESSEL PERMEABILITY; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETIC MACULAR EDEMA; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTOGRAPHY; RETINA; RETINA MACULA LUTEA; REVIEW; SLIT LAMP; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; VISUAL ACUITY;

EID: 55049133814     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007419     Document Type: Review

References (36)

1. Aiello 2005 Aiello LP. Angiogenic pathways in diabetic retinopathy. New England Journal of Medicine 2005;353(8):839-41.
2. Antcliff 1999 Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Seminars in Ophthalmology 1999;14(4):223- 32.
3. Arevalo 2007 Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, et al. Pan-American Collaborative Retina Study Goup. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results fromthe pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114(4):743-50.
4. Aroca 2004 Aroca PR, Salvat M, Fernandez J, Mendez I. Risk factors for diffuse and focal macular edema. Journal of Diabetic Complications 2004;18 (4):211-5.
5. Avery 2006 Avery RL, Pieramici DJ, Rabena MD. Intravitreal bevacizumab (Avastin) for neovascular age related macular degeneration. Ophthalmology 2006;113(3):363-72.
6. Bresnick 1976 Bresnick GH, Engerman R, Davis MD, de Venecia G, Myers FL. Patterns of ischemia in diabetic retinopathy. Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology 1976;81(4 Pt 1):OP694-709.
7. Bresnick 1983 Bresnick GH. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology 1983;90(11): 1301-17.
8. Bresnick 1984 Bresnick GH, Condit R, Syriala S, Palta M, Groo A, Korth K. Abnormalities of the foveal avascular zone in diabetic retinopathy. Archives of Ophthalmology 1984;102(9):1286-93.
9. Brown 2004 Brown JC, Solomon SD, Bressler SB, Schachat AP, DiBernardo C, Bressler NM. Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Archives of Ophthalmology 2004;122(3):330-5.
10. Ciulla 2003 Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003;26(9):2653-64.
11. Ciulla 2004 Ciulla TA, Walker JD, Fong DS, Criswell MH. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Current Opinions in Ophthalmology 2004;15(3):211-20.
12. Cunha-Vaz 1998 Cunha-Vaz J. Diabetic macular edema. European Journal of Ophthalmology 1998;8(3):127-30.
13. Cunningham 2005 Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, et al. Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112(10):1747-57.
14. Deeks 2008 Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
15. ETDRS 1985 Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology 1985;103(12):1796-806.
16. Ferrara 2004 Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nature Reviews. Drug Discovery 2004;3(5):391-400.
17. Ferrara 2006 Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 2006;26(8):859-70.
18. Ferris 1984 Ferris FL 3rd, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Archives of Ophthalmology 1984;102(11):1640-2.
19. Frank 2004 Frank RN. Diabetic Retinopathy. New England Journal of Medicine 2004;350(1):48-58.
20. Glanville 2006 Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
21. Gragoudas 2004 Gragoudas ES, Adamis AP, Cunningham ET Jr. Feinsod M, Guyer DR. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. New England Journal of Medicine 2004;351(27):2805-16.
22. Harbour 1996 Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen RE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. American Journal of Ophthalmology 1996;121(4):405-13.
23. Higgins 2008a Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
24. Higgins 2008b Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook. org.
25. Iturralde 2006 Iturralde D Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retina vein occlusion: a short-term study. Retina 2006;26(3):279-84.
26. Klein 1984 Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91(12):1464-74.
27. Kylstra 1999 Kylstra JA, Brown JC, Jaffe GJ, et al. The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. Ophthalmology 1999;106(11):2068-73.
28. Ladas 1993 Ladas ID, Theodossiadis GP. Long-term effectiveness of modified grid laser photocoagulation for diffuse diabetic macular edema. Acta Ophthalmologica 1993;71(3):393-7.
29. Lee 1991 Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.Ophthalmology 1991;98(10):1594-602.
30. Lewis 1992 Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99(5):753-59.
31. Presta 1997 Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Research 1997;57(20):4593-9.
32. Rosenfeld 2006 Rosenfeld PJ, Rich RM, Lalwani GA. Ranibizumab: Phase III clinical trial results. Ophthalmology Clinics of North America 2006;19(3):361-72.
33. Spaide 2006 Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26(3):275-8.
34. Ticho 1973 Ticho U, Patz A. The role of capillary perfusion in the management of diabetic macular edema. American Journal of Ophthalmology 1973;76(6):880-6.
35. Tranos 2004 Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Survey of Ophthalmology 2004;49(5):470-90.
36. Williams 2004 Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18(10):963-83.